Published in Oxid Med Cell Longev on January 13, 2015
Neuroprotective effects of dexmedetomidine against hyperoxia-induced injury in the developing rat brain. PLoS One (2017) 0.75
Neuroprotection by Caffeine in Hyperoxia-Induced Neonatal Brain Injury. Int J Mol Sci (2017) 0.75
The neuroprotective action of dexmedetomidine on apoptosis, calcium entry and oxidative stress in cerebral ischemia-induced rats: Contribution of TRPM2 and TRPV1 channels. Sci Rep (2016) 0.75
Dexmedetomidine reduces the neuronal apoptosis related to cardiopulmonary bypass by inhibiting activation of the JAK2-STAT3 pathway. Drug Des Devel Ther (2017) 0.75
Dexmedetomidine Prevents Lipopolysaccharide-Induced MicroRNA Expression in the Adult Rat Brain. Int J Mol Sci (2017) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet (2010) 26.48
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA (2009) 10.24
Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA (2012) 4.13
Dexmedetomidine as a total intravenous anesthetic agent. Anesthesiology (2004) 3.30
Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care (2000) 2.62
Dexmedetomidine attenuates isoflurane-induced neurocognitive impairment in neonatal rats. Anesthesiology (2009) 2.24
Neurodevelopmental outcomes of preterm infants. Curr Opin Neurol (2008) 1.97
A phase II/III, multicenter, safety, efficacy, and pharmacokinetic study of dexmedetomidine in preterm and term neonates. J Pediatr (2013) 1.67
The neuroprotective effect of dexmedetomidine in the hippocampus of rabbits after subarachnoid hemorrhage. Surg Neurol (2008) 1.57
Dexmedetomidine produces its neuroprotective effect via the alpha 2A-adrenoceptor subtype. Eur J Pharmacol (2004) 1.54
Dexmedetomidine provides cortical neuroprotection: impact on anaesthetic-induced neuroapoptosis in the rat developing brain. Acta Anaesthesiol Scand (2009) 1.50
Neurodevelopmental outcome of infants resuscitated with air or 100% oxygen: a systematic review and meta-analysis. Neonatology (2012) 1.39
Sedation during mechanical ventilation in infants and children: dexmedetomidine versus midazolam. South Med J (2004) 1.30
Results of a pilot study on the effects of propofol and dexmedetomidine on inflammatory responses and intraabdominal pressure in severe sepsis. J Clin Anesth (2009) 1.24
Oxygen causes cell death in the developing brain. Neurobiol Dis (2004) 1.18
Treatment-by-gender effect when aiming to avoid hyperoxia in preterm infants in the NICU. Acta Paediatr (2007) 1.17
Neuroprotective effects of dexmedetomidine in the gerbil hippocampus after transient global ischemia. Anesthesiology (1997) 1.11
Dexmedetomidine reduces isoflurane-induced neuroapoptosis partly by preserving PI3K/Akt pathway in the hippocampus of neonatal rats. PLoS One (2014) 1.10
The influence of dexmedetomidine on ischemic rat hippocampus. Brain Res (2008) 1.01
Effect of the alpha2-agonist dexmedetomidine on cerebral neurotransmitter concentrations during cerebral ischemia in rats. Anesthesiology (2002) 0.98
Hyperoxic exposure leads to cell death in the developing brain. Brain Dev (2008) 0.97
Awake craniotomy with dexmedetomidine in pediatric patients. J Neurosurg Anesthesiol (2003) 0.96
Dexmedetomidine-induced cerebral hypoperfusion exacerbates ischemic brain injury in rats. J Anesth (2009) 0.95
Erythropoietin protects the developing brain from hyperoxia-induced cell death and proteome changes. Ann Neurol (2008) 0.94
Dexmedetomidine versus standard therapy with fentanyl for sedation in mechanically ventilated premature neonates. J Pediatr Pharmacol Ther (2012) 0.93
Interaction of inflammation and hyperoxia in a rat model of neonatal white matter damage. PLoS One (2012) 0.93
Caspase-1-processed interleukins in hyperoxia-induced cell death in the developing brain. Ann Neurol (2005) 0.93
Pharmacological therapy for analgesia and sedation in the newborn. Arch Dis Child Fetal Neonatal Ed (2006) 0.92
Dexmedetomidine to treat opioid withdrawal in infants following prolonged sedation in the pediatric ICU. J Opioid Manag (2007) 0.92
Developmental age influences the effect of epidural dexmedetomidine on inflammatory hyperalgesia in rat pups. Anesthesiology (2005) 0.92
Dexmedetomidine provides neuroprotection: impact on ketamine-induced neuroapoptosis in the developing rat brain. Acta Anaesthesiol Scand (2014) 0.91
The development of antioxidant enzymatic defense in the perinatal rat lung: activities of superoxide dismutase, glutathione peroxidase, and catalase. Pediatr Res (1985) 0.91
Erythropoietin attenuates hyperoxia-induced oxidative stress in the developing rat brain. Brain Behav Immun (2009) 0.91
Dexmedetomidine inhibits tumor necrosis factor-alpha and interleukin 6 in lipopolysaccharide-stimulated astrocytes by suppression of c-Jun N-terminal kinases. Inflammation (2014) 0.90
Manipulation of gene expression by oxygen: a primer from bedside to bench. Pediatr Res (2009) 0.90
The effects of dexmedetomidine dosage on cerebral vasospasm in a rat subarachnoid haemorrhage model. J Clin Neurosci (2010) 0.87
Erythropoietin attenuates hyperoxia-induced cell death by modulation of inflammatory mediators and matrix metalloproteinases. Dev Neurosci (2009) 0.85
Procedural sedation and analgesia in pediatric patients. J Pediatr Neurosci (2014) 0.84
Neurodevelopmental outcomes of extremely preterm infants. Clin Perinatol (2013) 0.84
Sedation and analgesia in mechanically ventilated preterm neonates: continue standard of care or experiment? J Pediatr Pharmacol Ther (2012) 0.82
Caffeine protects neuronal cells against injury caused by hyperoxia in the immature brain. Free Radic Biol Med (2013) 0.82
Anesthetics and brain toxicity. Curr Opin Anaesthesiol (2005) 0.82
Successful use of dexmedetomidine for sedation in a 24-week gestational age neonate. Ann Pharmacother (2009) 0.82
Oxygen toxicity is reduced by acetylcholinesterase inhibition in the developing rat brain. Dev Neurosci (2013) 0.81
Dexmedetomidine inhibits inducible nitric oxide synthase in lipopolysaccharide-stimulated microglia by suppression of extracellular signal-regulated kinase. Neurol Res (2014) 0.80
Dexmedetomidine suppresses interleukin-1β-induced interleukin-6 synthesis in rat glial cells. Int J Mol Med (2014) 0.80
Neurotoxic effects of dexmedetomidine in fetal cynomolgus monkey brains. J Toxicol Sci (2014) 0.79
Bronchopulmonary dysplasia in preterm infants managed with non-invasive ventilation or surfactant and a brief period of mechanical ventilation: a 6-year cohort study. J Matern Fetal Neonatal Med (2013) 0.77
Dexmedetomidine renders a brain protection on hippocampal formation through inhibition of nNOS-NO signalling in endotoxin-induced shock rats. Brain Inj (2014) 0.77
Hyperoxia changes the balance of the thioredoxin/peroxiredoxin system in the neonatal rat brain. Brain Res (2012) 0.82
Erythropoietin Restores Long-Term Neurocognitive Function Involving Mechanisms of Neuronal Plasticity in a Model of Hyperoxia-Induced Preterm Brain Injury. Oxid Med Cell Longev (2016) 0.75